Your browser doesn't support javascript.
loading
Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.
Ke, Liangru; Zhou, Hufeng; Wang, Chong; Xiong, Geng; Xiang, Yanqun; Ling, Yihong; Khabir, Abdelmajid; Tsao, George S; Zeng, Yixin; Zeng, Musheng; Busson, Pierre; Kieff, Elliott; Guo, Xiang; Zhao, Bo.
Afiliação
  • Ke L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Zhou H; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
  • Wang C; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
  • Xiong G; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
  • Xiang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Ling Y; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
  • Khabir A; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Tsao GS; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Zeng Y; Pathology Department, Habib Bourguiba Hospital, 4100 Medenine, Tunisia.
  • Zeng M; School of Medicine, University of Sfax, 3029 Sfax, Tunisia.
  • Busson P; Department of Anatomy, Center for Cancer Research, University of Hong Kong, Hong Kong, People's Republic of China.
  • Kieff E; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Guo X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China; bzhao@bwh.harvard.edu guoxiang@sysucc.org.cn ekieff@bwh.harvard.edu pierre.busson@gustaveroussy.fr zengmsh@mail.sy
  • Zhao B; CNRS, UMR 8126, Gustave Roussy, Université Paris-Saclay, F-94805 Villejuif, France bzhao@bwh.harvard.edu guoxiang@sysucc.org.cn ekieff@bwh.harvard.edu pierre.busson@gustaveroussy.fr zengmsh@mail.sysu.edu.cn.
Proc Natl Acad Sci U S A ; 114(36): 9683-9688, 2017 09 05.
Article em En | MEDLINE | ID: mdl-28831010
ABSTRACT
Nasopharyngeal carcinoma (NPC) most frequently occurs in southern China and southeast Asia. Epidemiology studies link NPC to genetic predisposition, Epstein-Barr virus (EBV) infection, and environmental factors. Genetic studies indicate that mutations in chromatin-modifying enzymes are the most frequent genetic alterations in NPC. Here, we used H3K27ac chromatin immune precipitation followed by deep sequencing (ChIP-seq) to define the NPC epigenome in primary NPC biopsies, NPC xenografts, and an NPC cell line, and compared them to immortalized normal nasopharyngeal or oral epithelial cells. We identified NPC-specific enhancers and found these enhancers were enriched with nuclear factor κB (NF-κB), IFN-responsive factor 1 (IRF1) and IRF2, and ETS family members ETS1 motifs. Normal cell-specific enhancers were enriched with basic leucine zipper family members and TP53 motifs. NPC super-enhancers with extraordinarily broad and high H3K27ac signals were also identified, and they were linked to genes important for oncogenesis including ETV6. ETV6 was also highly expressed in NPC biopsies by immunohistochemistry. High ETV6 expression correlated with a poor prognosis. Furthermore, we defined the EBV episome epigenetic landscapes in primary NPC tissue.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Carcinoma / Neoplasias Nasofaríngeas / Elementos Facilitadores Genéticos / Proteínas Proto-Oncogênicas c-ets Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Carcinoma / Neoplasias Nasofaríngeas / Elementos Facilitadores Genéticos / Proteínas Proto-Oncogênicas c-ets Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article